arrow
C

Clair Blacketer

Johnson & Johnson
H指数:18
被引数:1,640

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes

真实世界证据表明,在老年2型糖尿病患者中,二线降糖药物的相对安全性比较。

2026-04-040
OAAI
A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine

基于真实世界数据网络的疫苗安全性监测快速循环分析框架:加强监测强生COVID-19疫苗的经验

VACCINE
IF3.5
2025-05-010
OAAI
Large-scale multinational trends in the use of cardioprotective antihyperglycemic agents as first-line therapy in patients with type 2 diabetes and cardiovascular disease: a LEGEND-T2DM study

大规模跨国趋势:在合并心血管疾病的2型糖尿病患者中,作为一线疗法使用心脏保护性降糖药物的情况——一项LEGEND-T2DM研究

2024-11-120
PRE
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
2023-10-0610
OAAI
Representing and utilizing clinical textual data for real world studies: An OHDSI approach
2023-06-017
OAAI
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
2023-04-016
OAAI
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
2022-06-0210
OAAI
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience
2021-09-0133
OA
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain
2021-07-1610
OAAI